Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bain Capital Specialty Finance (BCSF) Cash & Equivalents (2021 - 2025)

Bain Capital Specialty Finance (BCSF) has 4 years of Cash & Equivalents data on record, last reported at $40.9 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 61.33% year-over-year to $40.9 million; the TTM value through Sep 2025 reached $40.9 million, up 61.33%, while the annual FY2024 figure was $103.6 million, 7.91% down from the prior year.
  • Cash & Equivalents reached $40.9 million in Q3 2025 per BCSF's latest filing, down from $103.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $125.7 million in Q4 2022 and bottomed at $18.4 million in Q2 2024.
  • Average Cash & Equivalents over 4 years is $62.0 million, with a median of $46.7 million recorded in 2024.
  • The widest YoY moves for Cash & Equivalents: up 102.44% in 2024, down 79.01% in 2024.
  • A 4-year view of Cash & Equivalents shows it stood at $125.7 million in 2022, then fell by 10.54% to $112.5 million in 2023, then dropped by 7.91% to $103.6 million in 2024, then tumbled by 60.54% to $40.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $40.9 million in Q3 2025, $103.6 million in Q4 2024, and $25.3 million in Q3 2024.